Ballentine Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.35M | Sell |
|
|||||
|
2025
Q2 | $3.24M | Buy |
|
|||||
|
2025
Q1 | $2.86M | Buy |
|
|||||
|
2024
Q4 | $1.87M | Buy |
|
|||||
|
2024
Q3 | $2.12M | Buy |
|
|||||
|
2024
Q2 | $1.85M | Buy |
|
|||||
|
2024
Q1 | $1.49M | Buy |
|
|||||
|
2023
Q4 | $1.37M | Buy |
|
|||||
|
2023
Q3 | $1.15M | Buy |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $742K | Buy |
|
|||||
|
2022
Q4 | $717K | Sell |
|
|||||
|
2022
Q3 | $736K | Buy |
|
|||||
|
2022
Q2 | $816K | Sell |
|
|||||
|
2022
Q1 | $1.08M | Buy |
|
|||||
|
2021
Q4 | $756K | Buy |
|
|||||
|
2021
Q3 | $705K | Buy |
|
|||||
|
2021
Q2 | $740K | Sell |
|
|||||
|
2021
Q1 | $693K | Sell |
|
|||||
|
2020
Q4 | $813K | Buy |
|
|||||
|
2020
Q3 | $732K | Buy |
|
|||||
|
2020
Q2 | $700K | Sell |
|
|||||
|
2020
Q1 | $685K | Sell |
|
|||||
|
2019
Q4 | $837K | Buy |
|
|||||
|
2019
Q3 | $730K | Buy |
|
|||||
|
2019
Q2 | $761K | Sell |
|
|||||
|
2019
Q1 | $767K | Buy |
|
|||||
|
2018
Q4 | $655K | Buy |
|
|||||
|
2018
Q3 | $598K | Buy |
|
|||||
|
2018
Q2 | $516K | Buy |
|
|||||
|
2018
Q1 | $552K | Buy |
|
|||||
|
2017
Q4 | $561K | Buy |
|
|||||
|
2017
Q3 | $557K | Sell |
|
|||||
|
2017
Q2 | $563K | Buy |
|
|||||
|
2017
Q1 | $370K | Sell |
|
|||||
|
2016
Q4 | $403K | Buy |
|
|||||
|
2016
Q3 | $392K | Sell |
|
|||||
|
2016
Q2 | $417K | Buy |
|
|||||
|
2016
Q1 | $324K | Sell |
|
|||||
|
2015
Q4 | $398K | Buy |
|
|||||
|
2015
Q3 | $400K | Buy |
|
|||||
|
2015
Q2 | $382K | Hold |
|
|||||
|
2015
Q1 | $383K | Sell |
|
|||||
|
2014
Q4 | $1.38M | Buy |
|
|||||
|
2014
Q3 | $365K | Hold |
|
|||||
|
2014
Q2 | $351K | Hold |
|
|||||
|
2014
Q1 | $329K | Buy |
|
|||||
|
2013
Q4 | $293K | Hold |
|
|||||
|
2013
Q3 | $280K | Hold |
|
|||||
|
2013
Q2 | $258K | Buy |
|